Catastrophic Disruptions in Clinical Trials.
Publication
, Journal Article
Harrington, J; Felker, GM; Mentz, RJ
Published in: Circulation
August 2, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
August 2, 2022
Volume
146
Issue
5
Start / End Page
369 / 371
Location
United States
Related Subject Headings
- Treatment Outcome
- Humans
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrington, J., Felker, G. M., & Mentz, R. J. (2022). Catastrophic Disruptions in Clinical Trials. Circulation, 146(5), 369–371. https://doi.org/10.1161/CIRCULATIONAHA.122.060541
Harrington, Josephine, G Michael Felker, and Robert J. Mentz. “Catastrophic Disruptions in Clinical Trials.” Circulation 146, no. 5 (August 2, 2022): 369–71. https://doi.org/10.1161/CIRCULATIONAHA.122.060541.
Harrington J, Felker GM, Mentz RJ. Catastrophic Disruptions in Clinical Trials. Circulation. 2022 Aug 2;146(5):369–71.
Harrington, Josephine, et al. “Catastrophic Disruptions in Clinical Trials.” Circulation, vol. 146, no. 5, Aug. 2022, pp. 369–71. Pubmed, doi:10.1161/CIRCULATIONAHA.122.060541.
Harrington J, Felker GM, Mentz RJ. Catastrophic Disruptions in Clinical Trials. Circulation. 2022 Aug 2;146(5):369–371.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
August 2, 2022
Volume
146
Issue
5
Start / End Page
369 / 371
Location
United States
Related Subject Headings
- Treatment Outcome
- Humans
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology